Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Xiao Li, Lander Willem, Marina Antillon, Joke Bilcke, Mark Jit, Philippe Beutels

Journal title: BMC Medicine

Journal number: 18/1

Journal publisher: BioMed Central

Published year: 2020

DOI identifier: 10.1186/s12916-020-01537-6

ISSN: 1741-7015